Pilot Study to Identify and Validate Digital Biomarkers in Osteoarthritis of the Knee
DigitOAK
1 other identifier
interventional
43
1 country
1
Brief Summary
To date, treatment options for knee osteoarthritis remain limited, and their clinical evaluation is complex due to the day-to-day fluctuations in symptoms. Hospital tests provide a point-in-time measurement that is influenced by various factors (fatigue, recent activity, weather, etc.), making reliable assessment difficult. The aim of the study is to assess the feasibility and acceptability of monitoring actual activity using the Syde® portable device in up to 30 subjects. Numerical variables derived from data collected by Syde® will be compared with conventional on-site clinical assessment criteria and with data from healthy participants, in order to identify a reliable and robust metric, thereby improving treatment evaluation and personalised patient management. MAIN OBJECTIVES
- Evaluate the use of the device
- Identify numerical variables and determine the optimal time window for evaluation Patients will have two visits: one at inclusion and a second two months later. They will wear Syde® magneto-inertial sensors, one on each ankle, for the month following the initial visit, then a Syde® sensor on the ankle and another on the wrist on the side of the non-dominant hand for the following month. The total duration of the recording period is two months.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 14, 2025
CompletedFirst Submitted
Initial submission to the registry
May 15, 2025
CompletedFirst Posted
Study publicly available on registry
June 22, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 28, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
November 30, 2025
CompletedMarch 24, 2026
March 1, 2026
7 months
May 15, 2025
March 23, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Total Recording Time Over 2 Months
Total number of hours recorded by the Syde® wearable device over a 2-month period.
2 months
Median Daily Recording Time
Median number of hours recorded per day by the Syde® device over the 2-month period.
2 months
Days to Reach 180 Recording Hours
Number of days required to reach 180 hours of recording, considered the optimal threshold for analysis.
2 months
Intra-Class Correlation of Syde® Outcomes
Intra-Class Correlation (ICC) of each Syde® outcome calculated over slices of x hours (x = 10 to 90) of data per patient to assess reliability.
Entire recording period over 2 months
Secondary Outcomes (7)
Correlation Between Syde® Variables and WOMAC 3.1 Scores
Baseline and 2 months
Correlation Between Syde® Variables and Timed Tests
Baseline and 2 months
Correlation Between Syde® Variables and Kellgren-Lawrence Grade
Baseline
Discriminative Power of Syde® Variables
Entire recording period over 2 months
Qualitative Interview on Mobility and Usability
Baseline and Month 2
- +2 more secondary outcomes
Study Arms (2)
Patient with osteoarthritis of the knee
ACTIVE COMPARATORPatients will have two visits: one at inclusion and a second two months later. They will wear Syde® magneto-inertial sensors, one on each ankle, for the month following the initial visit, then a Syde® sensor on the ankle and another on the wrist on the side of the non-dominant hand for the following month. The total duration of the recording period is two months.
Healthy Subjects
ACTIVE COMPARATORHealthy subjects with similar age and BMI to patients with osteoarthritisof the knee
Interventions
Actimyo/Syde is an innovative device intended to be used in a home-based environment. It is composed of two watch-like sensors, each containing a magneto-inertial sensors that record the linear acceleration, the angular velocity, the magnetic field of the movement in all directions.The two watches can be worn as wristwatch or placed near the ankle.
Assesses walking speed over a fixed distance by having participants walk as quickly and safely as possible, but without running, along a 40-meter course.
It is a simple assessment of lower body strength and endurance. Participants are instructed to stand up and sit down from a chair as many times as possible in 30 seconds.
During this standardized test, the subject is observed and timed while he/she rises from a chair, walks 3 meters, performs a 180° turn, walk back toward the chair and sits down.
The WOMAC is a widely used self-administered health status measure for evaluating pain, stiffness, and function in patients with osteoarthritis of the hip or knee. The WOMAC measures three separate dimensions: pain (5 questions), stiffness (2 questions) and function (17 questions).
The PGI-S is a patient-reported measure that evaluates the perceived severity of a condition based on a standardized scale, ranging from "none" to "very severe".
Patients will record their specific OAK average pain level during the day using the VAS scale of 0-10 points for one week at the beginning of each month of recording.
This interview is designed to better understand the patient's perspective on the impact of osteoarthritis of the knee on their motor function and to inform the selection of digital tools in upcoming clinical studies.
Eligibility Criteria
You may qualify if:
- Patients with bi- or unilateral Knee Osteoarthritis as confirmed by a qualified rheumatologist/orthopaedist or rehabilitation doctor and having had at least one X-ray or MRI for diagnosis confirmation with Kellgren-Lawrence grade minimum 1
- WOMAC 3.1 total score at screening indicating mild, moderate, or severe symptoms in the past 48 hours
- BMI below 35.0 kg/m2
You may not qualify if:
- Patients with significant cognitive disorders, limiting the understanding of the exercises to be performed or the presence of apparent communication difficulties hindering the correct collection of data.
- Unable to walk independently (10 meters without any type of external help)
- History of any joint replacement surgery.
- Currently undergoing or had corticosteroid injections within the past 3 weeks.
- Underwent knee surgery in the past 6 months.
- Expecting joint replacement surgery or arthroscopy within 3 months.
- Pregnant women or women planning to become pregnant during the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Centre Hospitalier Universitaire de Liegelead
- Centre Hospitalier Régional de la Citadellecollaborator
- SYSNAVcollaborator
Study Sites (1)
Centre de référence des maladies neuromusculaire (CRMN Liège), Hopital de la Citadelle
Liège, 4000, Belgium
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Laurent Servais, MD, PhD
Centre Hospitalier Universitaire de Liege
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator, Neurologist
Study Record Dates
First Submitted
May 15, 2025
First Posted
June 22, 2025
Study Start
May 14, 2025
Primary Completion
November 28, 2025
Study Completion
November 30, 2025
Last Updated
March 24, 2026
Record last verified: 2026-03